1. Home
  2. SRI vs PLRX Comparison

SRI vs PLRX Comparison

Compare SRI & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$5.94

Market Cap

172.9M

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.24

Market Cap

93.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
PLRX
Founded
1965
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.9M
93.3M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
SRI
PLRX
Price
$5.94
$1.24
Analyst Decision
Buy
Hold
Analyst Count
1
11
Target Price
$16.00
$3.79
AVG Volume (30 Days)
140.2K
1.8M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$874,357,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.54
$1.10
52 Week High
$9.10
$15.00

Technical Indicators

Market Signals
Indicator
SRI
PLRX
Relative Strength Index (RSI) 48.26 34.01
Support Level $5.54 $1.17
Resistance Level $6.35 $1.35
Average True Range (ATR) 0.22 0.12
MACD 0.10 -0.03
Stochastic Oscillator 55.17 15.38

Price Performance

Historical Comparison
SRI
PLRX

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Share on Social Networks: